Clinical Trial Update: Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial assessing continuous intravenous lidocaine infusion during craniotomy tumor removal surgery (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniotomy Tumor Removal Surgery

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Indonesia University | Conditions: Craniotomy Tumor Removal Surgery | Phase 1, Phase 2 | Status: UNKNOWN